Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Koh

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Clinical Liver Disease|May 2, 2019
Noncirrhotic portal hypertension: An overviewOhad Etzion, Christopher Koh, Theo Heller
The Journal of Infectious Diseases|June 20, 2014
Understanding the presence of false-positive antibodies in acute hepatitisSasan Sakiani, Christopher Koh, Theo Heller
The Journal of Infectious Diseases|August 22, 2015
Reply to Tennant and PostSasan Sakiani, Christopher Koh, Theo Heller
Clinical Liver Disease|September 4, 2023
Noninvasive measures of portal hypertensionMaria Mironova, Christopher Koh, Theo Heller
World Journal of Gastroenterology|September 19, 2019
Chronic hepatitis delta: A state-of-the-art review and new therapiesChristy Gilman, Theo Heller, Christopher Koh
Current Opinion in Gastroenterology|February 14, 2018
Liver disease in patients with cystic fibrosisNatasha Kamal, Pallavi Surana, Christopher Koh
Hepatology (Baltimore, Md.)|April 15, 2018
Social media: Why AASLD and its members must lead the conversationTheo Heller, Christopher Koh, Sonal Kumar
Frontiers in Medicine|October 27, 2022
Current and investigational drugs in early clinical development for portal hypertensionSasan Sakiani, Theo Heller, Christopher Koh
Gastroenterology|October 22, 2018
Pathogenesis of and New Therapies for Hepatitis DChristopher Koh, Theo Heller, Jeffrey S Glenn
Hepatology (Baltimore, Md.)|September 19, 2019
ReplyBen L Da, Christopher Koh, Theo Heller
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Clinical Liver Disease|May 2, 2019
Noncirrhotic portal hypertension: An overviewOhad Etzion, Christopher Koh, Theo Heller
The Journal of Infectious Diseases|June 20, 2014
Understanding the presence of false-positive antibodies in acute hepatitisSasan Sakiani, Christopher Koh, Theo Heller
The Journal of Infectious Diseases|August 22, 2015
Reply to Tennant and PostSasan Sakiani, Christopher Koh, Theo Heller
Clinical Liver Disease|September 4, 2023
Noninvasive measures of portal hypertensionMaria Mironova, Christopher Koh, Theo Heller
World Journal of Gastroenterology|September 19, 2019
Chronic hepatitis delta: A state-of-the-art review and new therapiesChristy Gilman, Theo Heller, Christopher Koh
Current Opinion in Gastroenterology|February 14, 2018
Liver disease in patients with cystic fibrosisNatasha Kamal, Pallavi Surana, Christopher Koh
Hepatology (Baltimore, Md.)|April 15, 2018
Social media: Why AASLD and its members must lead the conversationTheo Heller, Christopher Koh, Sonal Kumar
Frontiers in Medicine|October 27, 2022
Current and investigational drugs in early clinical development for portal hypertensionSasan Sakiani, Theo Heller, Christopher Koh
Gastroenterology|October 22, 2018
Pathogenesis of and New Therapies for Hepatitis DChristopher Koh, Theo Heller, Jeffrey S Glenn
Hepatology (Baltimore, Md.)|September 19, 2019
ReplyBen L Da, Christopher Koh, Theo Heller
Pageof 16